Motley Fool6d agobullish
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.6d agoneutral
AbbVie (ABBV) Lands Phase 3 Migraine Study Win In The Lancet Neurology24/7 Wall St.6d agoneutral
4 Elite Dividend Stocks That Pay You Passive Income Every Quarter24/7 Wall St.6d agobullish
2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold ForeverMT Newswires6d agobullish
RBC Raises Price Target on AbbVie to $330 From $280, Keeps Outperform RatingGuruFocus.com6d agoneutral
What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 29Motley Fool6d agoneutral
Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's ComboSimply Wall St.8d agobullish
Is Earnings Beat Altering The Investment Case For AbbVie Stock (ABBV)?GuruFocus.com8d agoneutral
AbbVie Inc (ABBV) Q3 2026 Earnings Call Highlights: Raised Guidance, Immunology Momentum, and a ...Simply Wall St.38d agoneutral
AbbVie (ABBV) Stock May Be 41% Undervalued Following JUVMO Approval